BD Diagnostics Gets FDA Clearance for Second BD Max Staph Assay | GenomeWeb

NEW YORK (GenomeWeb News) — BD Diagnostics, a segment of Becton Dickinson, said today that it has received US Food and Drug Administration clearance to market its BD Max MRSA XT assay for use on the BD Max system.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Pacific Biosciences is hosting a competition in which researchers are vying to win free sequencing for an organism with the most interesting genome.

An opinion piece appearing in Newsday likens familial DNA searches to stop-and-frisk policies.

The San people of Africa have drawn up a code of conduct for researchers, according to the Conversation.

In Nature this week: genotypes linked to hip osteoarthritis, and more.